Amalgamated Bank Insmed Inc Transaction History

Amalgamated Bank

$12.1 Billion
Q3 2024

A detailed history of Amalgamated Bank transactions in Insmed Inc stock. As of the latest transaction made, Amalgamated Bank holds 5,327 shares of INSM stock, worth $404,212. This represents 0.0% of its overall portfolio holdings.

Number of Shares

5,327

Previous 5,327 -0.0%

Holding current value

$404,212

Previous $357,000 8.96%

% of portfolio

0.0%

Previous 0.0%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$22.0 - $69.71 $15,422 - $48,866	701 Added 15.15%	5,327 $357,000
Q1 2024 Apr 23, 2024	SELL	$25.72 - $29.94 $389,349 - $453,231	-15,138 Reduced 76.59%	4,626 $126,000
Q4 2023 Feb 06, 2024	SELL	$23.42 - $31.74 $15,902 - $21,551	-679 Reduced 3.32%	19,764 $612,000
Q3 2023 Nov 08, 2023	BUY	$19.86 - $26.93 $4,408 - $5,978	222 Added 1.1%	20,443 $516,000
Q2 2023 Aug 11, 2023	BUY	$16.44 - $21.1 $18,363 - $23,568	1,117 Added 5.85%	20,221 $426,000
Q1 2023 May 02, 2023	SELL	$16.26 - $21.73 $52,145 - $69,688	-3,207 Reduced 14.37%	19,104 $326,000
Q4 2022 Feb 10, 2023	BUY	$16.98 - $23.15 $52,960 - $72,204	3,119 Added 16.25%	22,311 $446,000
Q3 2022 Nov 09, 2022	BUY	$20.88 - $28.21 $6,389 - $8,632	306 Added 1.62%	19,192 $413,000
Q2 2022 Aug 15, 2022	SELL	$17.07 - $25.71 $7,630 - $11,492	-447 Reduced 2.31%	18,886 $372,000
Q1 2022 Jun 30, 2022	SELL	$20.42 - $28.13 $26,219 - $36,118	-1,284 Reduced 6.23%	19,333 $454,000
Q4 2021 Feb 15, 2022	BUY	$25.89 - $33.45 $4,711 - $6,087	182 Added 0.89%	20,617 $562,000
Q3 2021 Oct 29, 2021	BUY	$22.46 - $29.47 $21,022 - $27,583	936 Added 4.8%	20,435 $563,000
Q2 2021 Aug 16, 2021	BUY	$24.17 - $36.01 $122,904 - $183,110	5,085 Added 35.28%	19,499 $555,000
Q1 2021 May 13, 2021	SELL	$32.28 - $44.3 $45,482 - $62,418	-1,409 Reduced 8.9%	14,414 $491,000
Q4 2020 Feb 12, 2021	BUY	$31.45 - $40.54 $2,641 - $3,405	84 Added 0.53%	15,823 $526,000
Q3 2020 Oct 30, 2020	SELL	$26.0 - $34.5 $12,012 - $15,939	-462 Reduced 2.85%	15,739 $506,000
Q2 2020 Aug 10, 2020	BUY	$14.11 - $29.42 $5,079 - $10,591	360 Added 2.27%	16,201 $446,000
Q1 2020 May 13, 2020	SELL	$13.63 - $33.98 $5,506 - $13,727	-404 Reduced 2.49%	15,841 $254,000
Q4 2019 Feb 13, 2020	BUY	$16.12 - $24.98 $40,154 - $62,225	2,491 Added 18.11%	16,245 $388,000
Q3 2019 Nov 13, 2019	SELL	$15.49 - $25.78 $2,803 - $4,666	-181 Reduced 1.3%	13,754 $243,000
Q2 2019 Aug 14, 2019	BUY	$23.0 - $32.19 $47,909 - $67,051	2,083 Added 17.58%	13,935 $357,000
Q1 2019 May 15, 2019	BUY	$13.91 - $31.15 $4,270 - $9,563	307 Added 2.66%	11,852 $345,000
Q4 2018 Feb 15, 2019	BUY	$11.6 - $18.7 $133,922 - $215,891	11,545 New	11,545 $151,000
Q3 2018 Nov 14, 2018	SELL	$18.95 - $28.08 $221,696 - $328,507	-11,699 Closed	0 $0
Q2 2018 Jul 18, 2018	BUY	$20.0 - $29.72 $30,360 - $45,114	1,518 Added 14.91%	11,699 $277,000
Q1 2018 May 22, 2018	SELL	$21.69 - $32.99 $4,793 - $7,290	-221 Reduced 2.12%	10,181 $229,000
Q4 2017 Feb 13, 2018	BUY	$26.43 - $31.78 $25,663 - $30,858	971 Added 10.3%	10,402 $324,000
Q3 2017 Nov 09, 2017	BUY	$11.61 - $31.21 $109,493 - $294,341	9,431	9,431 $294,000

Others Institutions Holding INSM

# of Institutions

467

Shares Held

182M

Call Options Held

2.27M

Put Options Held

3.33M

View Full List

About INSMED Inc

Ticker INSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 135,476,992
Market Cap $10.3B
Description
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...

More about INSM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.

Account

Amalgamated Bank Insmed Inc Transaction History